PU-Boost: ATwo-StageReliable-Sample Reconstruction Positive-Unlabeled Learning Framework for Screening Undiagnosed Hypertension
Wu, H.; Shi, L.; Yang, H.; Li, B.; Wang, Q.; Zhan, Z.; Guo, L.
Show abstract
In hypertension screening, previously diagnosed cases provide reliable positive labels, whereas individuals without a prior diagnosis comprise both undiagnosed hypertensive and non-hypertensive individuals, creating a canonical positive-unlabeled (PU) learning setting. We propose PU-Boost, a two-stage reliable-sample reconstruction framework that uses only readily obtainable demographic, behavioral, medical-history, and anthropometric variables. During training, only previously diagnosed hypertension cases are treated as labeled positives (P), while all remaining individuals are treated as unlabeled (U); no additional reference labels are supplied to the two-stage reconstruction procedure. Elastic Net first provides a global ranking of P versus U, after which a random forest refines the uncertain region and highly ambiguous observations are rejected. XGBoost is then trained on the reconstructed class-balanced pseudo-labeled sample. In the independent test set, PU-Boost achieved a sensitivity of 0.817 and a balanced accuracy of 0.682, the highest observed values among the compared models. It produced 729 false negatives, 41.1% fewer than standard XGBoost, although specificity decreased to 0.547. SHAP analysis indicated that established hypertension-related features, including age, body mass index, waist circumference, and family history, contributed strongly to model output. PU-Boost therefore provides a statistically motivated framework for reducing missed cases when screening for undiagnosed hypertension under incomplete diagnostic labeling.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Advancing Cardiovascular Disease Diagnosis: A Robust ML Ecosystem Integrating Early Detection, Responsible AI Framework, and Causal Inference 94%
- Machine learning for classifying chronic kidney disease and predicting creatinine levels using at-home measurements 93%
- Can machine learning improve risk prediction of incident hypertension? An internal method comparison and external validation of the Framingham risk model using HUNT Study data 93%
Similar papers in this journal
- Enhanced machine learning and hybrid ensemble approaches for coronary heart disease prediction 94%
- Integrating feature importance techniques and causal inference to enhance early detection of heart disease 94%
- Rett syndrome severity estimation with the BioStamp nPoint using interactions between heart rate variability and body movement 92%
Similar papers in this journal
- A Transformer-Based Model Trained on Large Scale Claims Data for Prediction of Severe COVID-19 Disease Progression 93%
- Practical Strategies for Extreme Missing Data Imputation in Dementia Diagnosis 91%
- Evaluating Explanations from AI Algorithms for Clinical Decision-Making: A Social Science-based Approach 91%
Similar papers in this journal
- High-dimensional Biomarker Identification for Scalable and Interpretable Disease Prediction via Machine Learning Models 93%
- An Empirical Study on KDIGO-Defined Acute Kidney Injury Prediction in the Intensive Care Unit 92%
- PiDeel: Pathway-informed deep learning model for survivalanalysis and pathological classification of gliomas 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.